UNESCO, University of Dhaka, Renata organise global forum on cancer genetics
An international scientific programme on "Human Genome, Cancer and Cancer Genetic Counselling" was held on Saturday (27 September) at Dhaka Sheraton, Banani, jointly organised by UNESCO, the University of Dhaka, and Renata PLC.
The event brought together leading global experts in cancer research and genetics. Sir Walter Bodmer, Emeritus Professor at the University of Oxford, and Dr Joanne Ngeow, Senior Consultant at the National Cancer Centre Singapore, delivered keynote presentations on the latest advances in molecular oncology and genetic counselling.
Dr Ngeow highlighted that the proper use of genetic data can reduce overall healthcare costs by supporting early detection and prevention, which are less expensive than treating advanced disease. She emphasised that identifying high-risk individuals allows health systems to allocate resources more efficiently, benefitting both patients and providers.
Keep updated, follow The Business Standard's Google news channel
Sir Bodmer, a pioneer in human genetics and tumour immunology, noted that the human immune system often eliminates nascent cancer cells before they become life-threatening. He called for further research into biomarkers to predict cancer progression and stressed the role of genetic screening, immune profiling, and targeted therapy in shaping the future of cancer care. He also urged people to stop smoking, calling it the single largest cause of cancer worldwide.
Speakers at the open-floor discussion underscored the importance of genetic counselling in cancer prevention and treatment, while pointing to initiatives already underway in Bangladesh to collect genetic data for research and treatment purposes.
Syed Omar Kabir, Head of Pharmaceuticals Business & Operations at Renata PLC, delivered the vote of thanks, highlighting the importance of academic engagement, R&D, and genome system advancement in strengthening cancer research in Bangladesh.
The programme was attended by doctors, academics, oncologists, genetic researchers, healthcare professionals, and pharmaceutical representatives, making it a significant gathering for advancing cancer care and research. The event concluded with the distribution of tokens of appreciation and a group photo session with distinguished guests and participants.
